Stock Picks

ChromaDex Corporation CDXC Stock Report Date: March 2, 2025 Ticker: CDXC (NASDAQ) Current Price: $5.64 USD Market Cap: $426.04M Sector: Biotechnology / Healthy Aging Overview ChromaDex Corporation is a bioscience company specializing in healthy aging products, with a primary focus on nicotinamide adenine dinucleotide (NAD+) research and commercialization. Its flagship product, Niagen (nicotinamide riboside), is…